Dr. Rayne Rouce

Hematology | Oncology
Office
6701 Fannin St Ste 1410, 
Houston, TX 
14 Years of Experience
Office
6701 Fannin St Ste 1410, 
Houston, TX 

Overview

Rayne Rouce is a Hematologist and an Oncologist in Houston, Texas. Dr. Rouce has been practicing medicine for over 14 years. Her top areas of expertise are Infantile Neutropenia, Classical Hodgkin Lymphoma, T-Cell Lymphoma, and Small Lymphocytic Lymphoma (SLL).

Her clinical research consists of co-authoring 69 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Pediatrics in TX

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Office
6701 Fannin St Ste 1410, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes (LMP-TC) in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)
A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes (LMP-TC) in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)
Enrollment Status: Completed
Publish Date: January 26, 2026
Intervention Type: Biological
Study Drugs: Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes, Rituximab
Study Phase: Phase 2
A Phase II Trial of Tisagenlecleucel in First-line High-risk (HR) Pediatric and Young Adult Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL) Who Are Minimal Residual Disease (MRD) Positive at the End of Consolidation (EOC) Therapy
A Phase II Trial of Tisagenlecleucel in First-line High-risk (HR) Pediatric and Young Adult Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL) Who Are Minimal Residual Disease (MRD) Positive at the End of Consolidation (EOC) Therapy
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Biological
Study Drug: CTL019
Study Phase: Phase 2
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Drug, Biological, Procedure, Other, Radiation
Study Drugs: Brentuximab, Dacarbazine, Doxorubicin, Filgrastim, Nivolumab, Pegfilgrastim, Vinblastine
Study Phase: Phase 3
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Other, Drug, Biological
Study Drugs: Bleomycin, Brentuximab, Cyclophosphamide, Doxorubicin, Etoposide, Methylprednisolone, Prednisone, Vincristine
Study Phase: Phase 3
View 3 Less Clinical Trials

69 Total Publications

Conquering the gene and cell therapy viability crisis: A path paved by ASGCT.
Conquering the gene and cell therapy viability crisis: A path paved by ASGCT.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 01, 2025
Similar Doctors
William Wierda
Expertise in
28
conditions
Dr. William Wierda
Hematology | Oncology
Expertise in
28
conditions
Dr. William Wierda
Hematology | Oncology

University Of Texas MD Anderson Cancer Center

1515 Holcombe Blvd Unit 428, 
Houston, TX 
 (46.5 miles away)
713-792-7040
Languages Spoken:
English
See accepted insurances

William Wierda is a Hematologist and an Oncologist in Houston, Texas. Dr. Wierda is highly rated in 28 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Expertise in
18
conditions
Dr. Philip Thompson
Hematology | Oncology
Expertise in
18
conditions
Dr. Philip Thompson
Hematology | Oncology

Office

1400 Pressler St, 
Houston, TX 
 (46.2 miles away)
713-792-7430
Languages Spoken:
English
See accepted insurances

Philip Thompson is a Hematologist and an Oncologist in Houston, Texas. Dr. Thompson is highly rated in 18 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Splenectomy.

Expertise in
9
conditions
Dr. Carl Allen
Hematology | Oncology
Expertise in
9
conditions
Dr. Carl Allen
Hematology | Oncology

Office

1102 Bates Ave Ste 750, 
Houston, TX 
 (46.5 miles away)
832-824-4312
Languages Spoken:
English
See accepted insurances

Carl Allen is a Hematologist and an Oncologist in Houston, Texas. Dr. Allen is highly rated in 9 conditions, according to our data. His top areas of expertise are Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Transplant.

Frequently Asked Questions about Dr. Rayne Rouce

How do I make an appointment with Dr. Rayne Rouce?

You can book an appointment with Dr. Rayne Rouce by calling their office at 832-822-4242. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rayne Rouce a top-rated expert for Infantile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rayne Rouce is classified as an Experienced expert for Infantile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rayne Rouce specialize in?

While Dr. Rayne Rouce is a Hematology, they have specific expertise in Infantile Neutropenia, Classical Hodgkin Lymphoma, and T-Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Rayne Rouce participate in research or clinical trials?

Yes. Dr. Rayne Rouce has published 69 articles and abstracts on conditions like Infantile Neutropenia. You can view a list of Dr. Rayne Rouce's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rayne Rouce accept my insurance?

Dr. Rayne Rouce accepts most major insurance plans, including Blue Cross Blue Shield and Community Health Choice. We recommend calling the office directly at 832-822-4242 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rouce's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile